Moneycontrol PRO
HomeNewsOpinionMC Pro Quick Take: Sun Pharma’s US sales outpace Dr Reddy’s, Cipla in Q3

MC Pro Quick Take: Sun Pharma’s US sales outpace Dr Reddy’s, Cipla in Q3

Sun Pharma’s specialty drugs business continue to grow at a brisk pace, helped by ramp-up of key products

January 31, 2024 / 16:15 IST
Pharmaceutical industry
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts